IMET 3146: RN given refers to parent cpd without isomeric designation
ID Source | ID |
---|---|
PubMed CID | 134966 |
MeSH ID | M0079440 |
Synonym |
---|
32021-40-2 |
5-25-17-00018 (beilstein handbook reference) |
zimet 31/64 |
(+-)-alpha-amino-5-(bis(2-chloroethyl)amino)-1-phenyl-1h-benzimidazole-2-propanoic acid |
beta-(1-phenyl-5-bis-(beta-chloroethyl)amino-2-benzimidazolyl)-dl-alanine |
(+-)-alpha-amino-5-(bis(2-chloroethyl)amino)-1-phenyl-2-benzimidazolepropionic acid |
imet 3164 |
2-benzimidazolepropionic acid, alpha-amino-5-(bis(2-chloroethyl)amino)-1-phenyl-, (+-)- |
brn 4019059 |
zimet-3164 |
imet 3146 |
31539-54-5 |
3-{5-[bis(2-chloroethyl)amino]-1-phenyl-1h-benzimidazol-2-yl}alanine |
DTXSID80953520 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |